ABOUT US
The expert of molecular biology solutions for Humans
ID SOLUTIONS is an independent French company ISO 13485:2016, certified, specializing in the development of molecular biology solutions for research and diagnostics in human oncology and infectious diseases. Our vision for 2028 is to be the major player in molecular diagnostics in Europe, recognized by the scientific community, at the service of innovation for all.
Thanks to its expertise in the design, development, production and marketing of ergonomic, reliable and high-performance tests, ID SOLUTIONS went on to establish itself in the French market as a major player in health crisis management (COVID, MonkeyPox).
At the cutting edge of innovation, ID SOLUTIONS uses agility and adaptability to anticipate and respond to changing market requirements. In particular, ID SOLUTIONS was the first French manufacturer to offer kits for typing mutations in the virus responsible for COVID-19.
Building on this experience, ID SOLUTIONS has expanded its offering to include services for companies wishing to develop their molecular biology applications.
ID SOLUTIONS currently employs around 80 people, divided between two sites: Montpellier and Marseille.
Our mission
Revolutionizing diagnosis by improving the patient pathway
The healthcare and diagnostics sector demands a high level of responsiveness.
At ID SOLUTIONS, we are committed to delivering fast, accurate results in both infectious diseases and oncology. In order to improve treatment conditions for patients, it is essential to anticipate diseases.
Our objective is to make our tests as efficient and effective as possible, while remaining accessible and easy to use.
Lise GREWIS, CEO
Lise GREWIS is a scientist with over 15 years’ experience in the healthcare field. In 2016, she took part in the creation of ID SOLUTIONS, a French SME dedicated to cancer research in human health (circulating free DNA detection).
Frédéric FINA,
CSO
Frédéric FINA is a scientist with a PhD in molecular biology in the field of oncology, and over 25 years of experience in technology transfer. He has structured, developed and accredited technology platforms for the renowned Marseille Hospitals (AP-HM).
Christophe CARPENTIERI,
Marketing and Instrumentation Director
Christophe CARPENTIERI has a background in biotechnology and over 20 years of expertise in nucleic acid extraction and molecular biology. He is currently technical manager for ID SOLUTIONS instrumentation.
Lise GREWIS, CEO
Lise GREWIS is a scientist with over 15 years’ experience in the healthcare field. In 2016, she took part in the creation of ID SOLUTIONS, a French SME dedicated to cancer research in human health (circulating free DNA detection).
Frédéric FINA,
Directeur général et scientifique
Frédéric FINA is a scientist with a PhD in molecular biology in the field of oncology, and over 25 years of experience in technology transfer. He has structured, developed and accredited technology platforms for the renowned Marseille Hospitals (AP-HM).
Christophe CARPENTIERI,
Directeur Général, Marketing
& Commercial
Christophe CARPENTIERI has a background in biotechnology and over 20 years of expertise in nucleic acid extraction and molecular biology. He is currently technical manager for ID SOLUTIONS instrumentation.
Core values
Our expertise is in your hands
Innovation
Provide access to new technologies and services, improving accuracy, efficiency and accessibility for the benefit of all.
Agility
Preserve our ability to adapt to market specificities and needs as quickly as possible
Integrity
Guarantee the reliability of results and the confidence of stakeholders through ethical conduct in compliance with professional standards.
Quality Policy
Our engagements
Trust
Controlling our service providers and suppliers
Security
Ensure the monitoring of our devices through the Reactovigilance process and technical support
Monitoring
Measure our performance with appropriate evaluation tools and indicators
Developpement
Implement training and skills development programs
Satisfaction
Improving customer and patient satisfaction
Rigor
Meeting regulatory requirements
Trust
Controlling our service providers and suppliers
Security
Ensure the monitoring of our devices through the Reactovigilance process and technical support
Monitoring
Measure our performance with appropriate evaluation tools and indicators
Developpement
Implement training and skills development programs
Satisfaction
Improving customer and patient satisfaction
Rigor
Meeting regulatory requirements
